Buy Tazarotene (Tazorac) gel online
(trade names include Tazorac, Fabior, Tazotop, Tazret, Zorac
) is a dermatological medication from antipsoriatics for topical use pharmacological group. This medicine is used for the treatment of psoriasis, acne, photodamage (sun damaged skin), including associated with skin irritation and erythema; to reduce skin wrinkling and liver spots. It works as retinoid prodrug by affecting the growth of skin cells.
How and where to order Tazarotene (Tazorac) 0.05% 50 g gel online:
: BUY TAZAROTENE ONLINE
from $25.99 per pill
5% coupon: 5OFF
Tazarotene (Tazorac) 0.05% 50 g topical gel
Tazorac (Tazarotene) generic
Visa, MasterCard, AmEx, JCB, Bitcoin
Unregistered Mail and Trackable Courier
Worldwide, including USA, UK, Europe, Canada, Australia
Azelaic Acid (Azelex)
Benzoyl Peroxide (Benzac)
Calcipotriol, Betamethasone (Daivobet)
Calcitriol (Rocaltrol, Calcijex)
Clindamycin, Tretinoin (Ziana)
Fumaric Acid (Lichenic Acid)
Pharmacological and medical categories:
Anti acne medications
Anti psoriasis drugs
Photodamaged skin treatment
Skin care products
Vitamin A derivatives
D - Dermatologicals
D05 - Antipsoriatics
D05A - Antipsoriatics for topical use
D05AX - Other antipsoriatics for topical use
D05AX05 - Tazarotene
Psoriasis - L40
Other erythematous conditions - L53
Other acute skin changes due to ultraviolet radiation - L56
Acne - L70
Other disorders of pigmentation - L81
Other melanin hyperpigmentation - L81.4
Other disorders of skin and subcutaneous tissue, not elsewhere classified - L98
X - Australia
X - United States (Should not be used during pregnancy)
Salts and other forms:
Synonyms, international and chemical names:
Brands, generics, trade names:
Avage - Sanofi-Aventis, Allergan, IDS Group
Fabior - Mayne Pharma
Tazorac - Allergan, Medibrands, Pierre Fabre
Tazotop - Sun Pharmaceutical Industries
Tazret - Glenmark Pharmaceuticals
Zorac - Allergan, Pierre Fabre
Indications and usage:
Tazorac (Tazarotene) cream and gel 0.05% and 0.1% is a retinoid indicated for the topical treatment of plaque psoriasis.
Tazarotene gel and cream 0.1% is indicated for the topical treatment of acne vulgaris.
Dosage and administration:
Apply a thin layer of Tazorac (Tazarotene) cream or gel only to the affected area once daily in the evening.
Not for ophthalmic, oral, or intravaginal use.
If contact with eyes occurs, rinse thoroughly with water.
Dosage forms and strengths:
Tazarotene cream, gel 0.05% and 0.1%.
Warnings and precautions:
Embryofetal Toxicity: Tazorac cream and gel contains tazarotene, which is a teratogenic substance. Tazarotene is contraindicated in pregnancy. Females of child-bearing potential should have a negative pregnancy test within 2 weeks prior to initiating treatment and use an effective method of contraception during treatment.
Local Irritation: Some individuals may experience excessive pruritus, burning, skin redness or peeling. If these effects occur, discontinue until the integrity of the skin has been restored, or reduce dosing interval, or in the case of psoriasis, may switch to the lower concentration. Tazorac gel and cream should not be used on eczematous skin, as it may cause severe irritation.
Photosensitivity and Risk for Sunburn: Avoid exposure to sunlight, sunlamps, and weather extremes. Wear sunscreen daily. Tazarotene gel or cream should be administered with caution if the patient is also taking drugs known to be photosensitizers.
Adverse reactions, side effects:
Plaque psoriasis: Most common adverse reactions occurring in 10 to 23% of patients are pruritus, erythema, and burning.
Acne Vulgaris: Most common adverse reactions occurring in 10 to 30% of patients are desquamation, dry skin, erythema, and burning sensation.
Updated: February 2020
Reviewed: February 2020
"We provided some exciting changes to the study plan within a couple of weeks of treatment dates and the team stepped up, as usual, and put a plan into place to give us the highest chance of success utilizing the criteria we requested."
Our expert preclinical Surgeons and Interventionalists can assist with human factors assessments and evaluating prototypes for your GLP or nonGLP preclinical studies.